Evidence map›Paper›PMID 32393887›Full record

ArticleNature cell biology2020

The HOIL-1L ligase modulates immune signalling and cell death via monoubiquitination of LUBAC.

Yasuhiro Fuseya, Hiroaki Fujita, Minsoo Kim, Fumiaki Ohtake, Akira Nishide, Katsuhiro Sasaki, Yasushi Saeki, Keiji Tanaka, Ryosuke Takahashi, Kazuhiro Iwai

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Physiological functions of ULK1/2.Journal of molecular biology · 2024
    Review
  16. Article
  17. Article
  18. Dominant negative OTULIN-related autoinflammatory syndrome.The Journal of experimental medicine · 2024
    Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yasuhiro FuseyaDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-3281-6074
Hiroaki FujitaDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Minsoo KimDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-8536-8653
Fumiaki OhtakeLaboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Akira NishideDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-3524-5019
Katsuhiro SasakiDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6211-9088
Yasushi SaekiLaboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9202-5453
Keiji TanakaLaboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Ryosuke TakahashiDepartment of Neurology, Graduate School of Medicine, Kyoto University Hospital, Kyoto, Japan.ORCID http://orcid.org/0000-0002-1407-9640
Kazuhiro IwaiDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. kiwai@mcp.med.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0001-5620-5951
Kyoto University · JPTokyo Metropolitan Institute of Medical Science · JPHoshi University · JPKyoto University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The linear ubiquitin chain assembly complex (LUBAC), which consists of HOIP, SHARPIN and HOIL-1L, promotes NF-κB activation and protects against cell death by generating linear ubiquitin chains. LUBAC contains two RING-IBR-RING (RBR) ubiquitin ligases (E3), and the HOIP RBR is responsible for catalysing linear ubiquitination. We found that HOIL-1L RBR plays a crucial role in regulating LUBAC. HOIL-1L RBR conjugates monoubiquitin onto all LUBAC subunits, followed by HOIP-mediated conjugation of linear chains onto monoubiquitin, and these linear chains attenuate the functions of LUBAC. The introduction of E3-defective HOIL-1L mutants into cells augmented linear ubiquitination, which protected the cells against Salmonella infection and cured dermatitis caused by reduced LUBAC levels due to SHARPIN loss. Our results reveal a regulatory mode of E3 ligases in which the accessory E3 in LUBAC downregulates the main E3 by providing preferred substrates for autolinear ubiquitination. Thus, inhibition of HOIL-1L E3 represents a promising strategy for treating severe infections or immunodeficiency.

Indexed as

Cell DeathAnimalsCarrier ProteinsCells, CulturedChemical and Drug Induced Liver InjuryDermatitis, ContactEmbryo, MammalianFibroblastsGene Expression RegulationIntracellular Signaling Peptides and ProteinsMice, KnockoutNF-kappa BSalmonellaSalmonella Infections, AnimalSeverity of Illness IndexSignal TransductionCarrier ProteinsIntracellular Signaling Peptides and ProteinsNF-kappa BRbck1 protein, mouseRnf31 protein, mouseSipl1 protein, mouseUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID32393887
OpenAlexW3023308582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.